Cyclo Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cyclo Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Cyclo Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 28.7M shares, a 87.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 28.7M +13.4M +87.5% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 28.6M +18.6M +185% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 28.6M +20.1M +237% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 19.4M +10.9M +129% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 15.3M +6.87M +81.4% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 10.1M +1.64M +19.5% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 8.48M +78K +0.93% Dec 31, 2022 10-K 2024-03-18
Q3 2022 8.46M +2M +31% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 8.44M +2M +31.1% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 8.42M +2.06M +32.4% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 8.4M +3.63M +76.2% Dec 31, 2021 10-K 2023-03-17
Q3 2021 6.45M -163M -96.2% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 6.44M -135M -95.5% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 6.36M -115M -94.8% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 4.77M +3.56M +292% Dec 31, 2020 10-K 2022-03-11
Q3 2020 170M +48.8M +40.3% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 142M +21.1M +17.5% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 122M +30.8M +33.9% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 1.22M -89.5M -98.7% Dec 31, 2019 10-K 2021-03-12
Q3 2019 121M +33.9M +38.8% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 121M +33.3M +38.2% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 90.8M +17.8M +24.3% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 90.8M +17.8M +24.3% Dec 31, 2018 10-K 2020-03-30
Q3 2018 87.2M +14.2M +19.5% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 87.2M +14.4M +19.7% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 73M +112K +0.15% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 73M +6.05M +9.03% Dec 31, 2017 10-K 2019-03-15
Q3 2017 73M +6.05M +9.03% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 72.9M +6.21M +9.31% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 72.9M +14.2M +24.2% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 67M +8.28M +14.1% Dec 31, 2016 10-K 2018-04-16
Q3 2016 67M +8.28M +14.1% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 66.7M +12.2M +22.4% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 58.7M +4.21M +7.74% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 58.7M +4.25M +7.81% Dec 31, 2015 10-K 2017-03-17
Q3 2015 58.7M +4.39M +8.09% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 54.5M +2M +3.81% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 54.5M +6M +12.4% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 54.4M +17M +45.3% Dec 31, 2014 10-K 2016-03-30
Q3 2014 54.3M +16.8M +44.9% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 52.5M +15.6M +42.2% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 48.5M +11.6M +31.4% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 37.5M +566K +1.54% Dec 31, 2013 10-K 2015-03-27
Q3 2013 37.5M +566K +1.54% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 36.9M +314K +0.86% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 36.9M +314K +0.86% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 36.9M +314K +0.86% Dec 31, 2012 10-K 2014-03-04
Q3 2012 36.9M +642K +1.77% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 36.6M +1.06M +2.99% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 36.6M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 36.6M +1.17M +3.29% Dec 31, 2011 10-K 2013-03-14
Q3 2011 36.2M Sep 30, 2011 10-Q/A 2012-02-23
Q2 2011 35.5M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 35.4M Dec 31, 2010 10-K 2012-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.